These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21175445)

  • 1. (R)- and (S)-methadone and buprenorphine concentration ratios in maternal and umbilical cord plasma following chronic maintenance dosing in pregnancy.
    Gordon AL; Lopatko OV; Somogyi AA; Foster DJ; White JM
    Br J Clin Pharmacol; 2010 Dec; 70(6):895-902. PubMed ID: 21175445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buprenorphine exposure in infants of opioid-dependent mothers at birth.
    Bartu AE; Ilett KF; Hackett LP; Doherty DA; Hamilton D
    Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):342-7. PubMed ID: 22428721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Umbilical cord monitoring of in utero drug exposure to buprenorphine and correlation with maternal dose and neonatal outcomes.
    Concheiro M; Jones HE; Johnson RE; Choo R; Shakleya DM; Huestis MA
    J Anal Toxicol; 2010 Oct; 34(8):498-505. PubMed ID: 21819795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child.
    Zedler BK; Mann AL; Kim MM; Amick HR; Joyce AR; Murrelle EL; Jones HE
    Addiction; 2016 Dec; 111(12):2115-2128. PubMed ID: 27223595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UHPLC-MS/MS quantification of buprenorphine, norbuprenorphine, methadone, and glucuronide conjugates in umbilical cord plasma.
    Kyle AR; Carmical J; Shah D; Pryor J; Brown S
    Biomed Chromatogr; 2015 Oct; 29(10):1567-74. PubMed ID: 25808363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrected QT Interval and Methadone Dose and Concentrations in Pregnant and Postpartum Women.
    Bogen DL; Hanusa BH; Perel JM; Sherman F; Mendelson MA; Wisner KL
    J Clin Psychiatry; 2017; 78(8):e1013-e1019. PubMed ID: 28994902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy.
    Johnson S; Martin PR
    Am J Drug Alcohol Abuse; 2018; 44(3):310-316. PubMed ID: 28829626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Maternal Buprenorphine or Methadone Dose with Fetal Growth Indices and Neonatal Abstinence Syndrome.
    Coulson CC; Lorencz E; Rittenhouse K; Ramage M; Lorenz K; Galvin SL
    Am J Perinatol; 2021 Jan; 38(1):28-36. PubMed ID: 31421639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes.
    de Castro A; Jones HE; Johnson RE; Gray TR; Shakleya DM; Huestis MA
    Ther Drug Monit; 2011 Aug; 33(4):443-52. PubMed ID: 21743375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal assessment before and after dosing with buprenorphine or methadone.
    Salisbury AL; Coyle MG; O'Grady KE; Heil SH; Martin PR; Stine SM; Kaltenbach K; Weninger M; Jones HE
    Addiction; 2012 Nov; 107 Suppl 1(0 1):36-44. PubMed ID: 23106925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance agonist treatments for opiate-dependent pregnant women.
    Minozzi S; Amato L; Bellisario C; Ferri M; Davoli M
    Cochrane Database Syst Rev; 2013 Dec; (12):CD006318. PubMed ID: 24366859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Management of Opioid Use Disorder in Pregnant Women.
    Wilder CM; Winhusen T
    CNS Drugs; 2015 Aug; 29(8):625-36. PubMed ID: 26315948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MATERNAL AND FETAL BUPRENORPHINE PHARMACOKINETICS IN PREGNANT SHEEP DURING TRANSDERMAL PATCH DOSING: Buprenorphine pharmacokinetics in pregnant sheep.
    Hakomäki H; Kokki H; Lehtonen M; Räsänen J; Voipio HM; Ranta VP; Kokki M
    Eur J Pharm Sci; 2021 Oct; 165():105936. PubMed ID: 34273481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal neurobehavioral effects of exposure to methadone or buprenorphine.
    Jansson LM; Dipietro JA; Velez M; Elko A; Williams E; Milio L; O'Grady K; Jones HE
    Neurotoxicol Teratol; 2011; 33(2):240-3. PubMed ID: 20868741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of R- and S-methadone into human milk during multiple, medium to high oral dosing.
    Begg EJ; Malpas TJ; Hackett LP; Ilett KF
    Br J Clin Pharmacol; 2001 Dec; 52(6):681-5. PubMed ID: 11736879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication-Assisted Treatment Use Among Pregnant Women With Opioid Use Disorder.
    Krans EE; Kim JY; James AE; Kelley D; Jarlenski MP
    Obstet Gynecol; 2019 May; 133(5):943-951. PubMed ID: 30969219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
    Kelty E; Hulse G
    Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated infant exposure to enantiomer-specific methadone levels in breastmilk.
    Bogen DL; Perel JM; Helsel JC; Hanusa BH; Thompson M; Wisner KL
    Breastfeed Med; 2011 Dec; 6(6):377-84. PubMed ID: 21348770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Breast feeding during methadon- and buprenorphin therapy].
    Müller MJ; Lange M; Paul T; Seeliger S
    Klin Padiatr; 2011 Dec; 223(7):408-13. PubMed ID: 21969026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of symptom reporting during pregnancy comparing opioid maintained and control women.
    Gordon AL; Lopatko OV; Stacey H; Pearson V; Woods A; Fisk A; White JM
    J Addict Med; 2012 Dec; 6(4):258-64. PubMed ID: 23135165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.